Page last updated: 2024-08-26

1-methyltryptophan and Breast Cancer

1-methyltryptophan has been researched along with Breast Cancer in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (20.00)24.3611
2020's4 (80.00)2.80

Authors

AuthorsStudies
Fan, D; Fang, J; Feng, C; He, L; Liang, W; Qin, X; Wang, Q1
Piyu, J; Song, J; Yi, X; Zang, X1
Chen, C; Du, W; Fan, C; Jiang, X; Liu, Y; Sun, P; Wu, J; Yan, C; Zhang, J; Zhang, R; Zhang, S; Zhang, X1
Danciu, O; Dillon, P; Gilman, P; Han, H; Ibrahim, NK; Ismail-Khan, R; Kennedy, E; Link, C; Mariotti, V; Melin, S; Montero, AJ; Poklepovic, A; Schuster, S; Smith, C; Soliman, H; Tang, SC; Tennant, L; Vahanian, N1
da Cunha Bianchi, PK; Gebrim, LH; Kfoury, JR; Salvadori, ML; Silva, RS1

Trials

1 trial(s) available for 1-methyltryptophan and Breast Cancer

ArticleYear
Effect of Taxane Chemotherapy With or Without Indoximod in Metastatic Breast Cancer: A Randomized Clinical Trial.
    JAMA oncology, 2021, Jan-01, Volume: 7, Issue:1

    Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Female; Humans; Middle Aged; Prospective Studies; Taxoids; Tryptophan

2021

Other Studies

4 other study(ies) available for 1-methyltryptophan and Breast Cancer

ArticleYear
Injectable Micelle-Incorporated Hydrogels for the Localized Chemo-Immunotherapy of Breast Tumors.
    ACS applied materials & interfaces, 2021, Oct-06, Volume: 13, Issue:39

    Topics: Animals; Antineoplastic Agents; Breast Neoplasms; CD8-Positive T-Lymphocytes; Cell Line, Tumor; Chondroitin Sulfates; Delayed-Action Preparations; Deoxycytidine; Enzyme Inhibitors; Female; Gemcitabine; Hydrogels; Immunotherapy; Indoleamine-Pyrrole 2,3,-Dioxygenase; Mice, Inbred BALB C; Micelles; Neoplasm Metastasis; Poloxamer; Tryptophan; Tumor Microenvironment

2021
Polymeric indoximod based prodrug nanoparticles with doxorubicin entrapment for inducing immunogenic cell death and improving the immunotherapy of breast cancer.
    Journal of materials chemistry. B, 2022, 03-23, Volume: 10, Issue:12

    Topics: Animals; Breast Neoplasms; Cell Line, Tumor; Doxorubicin; Female; Humans; Immunogenic Cell Death; Immunologic Factors; Immunotherapy; Mice; Nanoparticles; Polymers; Prodrugs; Tryptophan; Tumor Microenvironment; Vascular Endothelial Growth Factor A

2022
Eliciting an immune hot tumor niche with biomimetic drug-based multi-functional nanohybrids augments immune checkpoint blockade-based breast cancer therapy.
    Nanoscale, 2020, Feb-07, Volume: 12, Issue:5

    Topics: Animals; Biomimetic Materials; Breast Neoplasms; Female; Humans; MCF-7 Cells; Mice, Inbred BALB C; Nanoparticles; Oxaliplatin; Tryptophan; Tumor Microenvironment; Xenograft Model Antitumor Assays

2020
Effect of the association of 1-methyl-DL-tryptophan with paclitaxel on the expression of indoleamine 2,3-dioxygenase in cultured cancer cells from patients with breast cancer.
    Medical oncology (Northwood, London, England), 2015, Volume: 32, Issue:11

    Topics: Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Female; Gene Expression Regulation, Neoplastic; Humans; Indoleamine-Pyrrole 2,3,-Dioxygenase; Paclitaxel; Tryptophan; Tumor Cells, Cultured

2015